Title : Circulating Androgen Receptor for Prognosis and Treatment Selection in Prostate Cancer.

Pub. Date : 2021 Oct

PMID : 33436326






3 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Analysis of androgen receptor (AR) status, particularly AR copy number, in plasma DNA is a minimally invasive method with the potential to identify treatment resistance in patients with castration-resistant prostate cancer (CRPC) starting enzalutamide or abiraterone. enzalutamide androgen receptor Homo sapiens
2 Analysis of androgen receptor (AR) status, particularly AR copy number, in plasma DNA is a minimally invasive method with the potential to identify treatment resistance in patients with castration-resistant prostate cancer (CRPC) starting enzalutamide or abiraterone. enzalutamide androgen receptor Homo sapiens
3 Analysis of androgen receptor (AR) status, particularly AR copy number, in plasma DNA is a minimally invasive method with the potential to identify treatment resistance in patients with castration-resistant prostate cancer (CRPC) starting enzalutamide or abiraterone. enzalutamide androgen receptor Homo sapiens